The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kassler-taub Kenneth B. since 2022.
This trader's CIK number is 1885219.
At the time of last reporting, Kassler-taub Kenneth B. was the SVP, Regulatory & QA of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX).
Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | LXRX | 0 | $0 | 0 | $0 | 52,886 | $0 |
| 2022 | LXRX | 0 | $0 | 0 | $0 | 36,628 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-28 | LXRX | Option Ex | 52,886 | .00 | 0 |
| 2022-02-28 | LXRX | Option Ex | 36,628 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kassler-taub Kenneth B. (SVP, Regulatory & QA of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.